title: The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
abstract: Incretin hormones are secreted from the intestines in response to specific nutrients. They potentiate insulin secretion and have other beneficial effects in glucose homeostasis. We aimed to study the incretin effect in cats and to compare the effect of oral glucose, lipids, or amino acids on serum concentrations of insulin, total glucose-dependent insulinotropic peptide (GIP) and total glucagon-like peptide 1 (GLP-1). Ten healthy cats were used in a repeated measures design. Glucose, lipid, or amino acids were administered through nasoesophageal tubes on separate days. Blood glucose (BG) concentrations were matched between experiments by measuring BG every 5 min and infusing glucose intravenously at a changing rate. Intravenous glucose infusion with no prior treatment served as control. The incretin effect was estimated as the difference in insulin area under the curve (AUC) after oral compared with intravenous glucose. Temporal changes and total amount of hormone secretions were compared between treatment groups with the use of mixed models. Total glucose infused (TGI) at a mean dose of 0.49 g/kg resulted in slightly higher BG compared with 1 g/kg oral glucose (P = 0.038), but insulin concentrations were not significantly different (P = 0.367). BG and the TGI were not significantly different after the 3 oral challenges. Total GIP AUC was larger after lipids compared with amino acids (P = 0.0012) but GIP concentrations did not increase after oral glucose. Insulin and GIP concentrations were positively correlated after lipid (P < 0.001) and amino acids (P < 0.001) stimulations, respectively, but not after oral glucose stimulation. Total GLP-1 AUC was similar after all three oral stimulations. Insulin and GLP-1 concentrations were positively correlated after glucose (P = 0.001), amino acids (P < 0.001), or lipids (P = 0.001) stimulations. Our data indirectly support an insulinotropic effect of GIP and GLP-1. Potentiation of insulin secretion after oral glucose is minimal in cats and is mediated by GLP-1 but not GIP.
authors.affiliation: Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, 1008 West Hazelwood Drive, Urbana, IL 61802, USA.
authors.forename: C
authors.initials: C
authors.lastname: Gilor
authors.forename: T K
authors.initials: TK
authors.lastname: Graves
authors.forename: S
authors.initials: S
authors.lastname: Gilor
authors.forename: T K
authors.initials: TK
authors.lastname: Ridge
authors.forename: H-Y
authors.initials: HY
authors.lastname: Weng
authors.forename: O
authors.initials: O
authors.lastname: Dossin
mesh_terms: D000596:Amino Acids / Q000008:administration & dosage; D000818:Animals; D019540:Area Under Curve; D001786:Blood Glucose / Q000032:analysis; D002415:Cats / Q000097:blood / Q000502:physiology*; D005260:Female; D005749:Gastric Inhibitory Polypeptide / Q000097:blood / Q000378:metabolism*; D052216:Glucagon-Like Peptide 1 / Q000097:blood / Q000378:metabolism*; D005947:Glucose / Q000008:administration & dosage*; D054795:Incretins / Q000097:blood / Q000378:metabolism*; D007328:Insulin / Q000097:blood* / Q000378:metabolism; D000078790:Insulin Secretion; D008055:Lipids / Q000008:administration & dosage; D008297:Male
chemical_list: D000596:Amino Acids; D001786:Blood Glucose; D054795:Incretins; D007328:Insulin; D008055:Lipids; D005749:Gastric Inhibitory Polypeptide; D052216:Glucagon-Like Peptide 1; D005947:Glucose